Earnings History Data for Hemispherx BioPharma, Inc. (AIM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Hemispherx BioPharma, Inc.

AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is based in Ocala, Florida.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2023	PM		AIM	Hemispherx BioPharma, Inc.	20.59	-0.16	0.00	-0.13	AIM ImmunoTech GAAP EPS of -$0.16 misses by $0.04 [11/15/2023 7:37 AM]	0.4748	0.02 (4.58%)	0.48	0.03 (5.73%)	0.29 - 0.84	75,474	200,000	644
AIM ImmunoTech GAAP EPS of -$0.16 misses by $0.04 [11/15/2023 7:37 AM]
15-08-2023	PM		AIM	Hemispherx BioPharma, Inc.	28.25	-0.10	0.00	-0.10	AIM ImmunoTech GAAP EPS of -$0.10 beats by $0.01, revenue of $0.04M beats by $0.02M [8/15/2023 6:10 AM]	0.6473	-0.04 (-5.64%)	0.69	0.0 (0.00%)	0.29 - 0.84	162,863	110,000	2,692
AIM ImmunoTech Q2 2023 Earnings Preview [8/14/2023 2:27 PM] AIM ImmunoTech GAAP EPS of -$0.10 beats by $0.01, revenue of $0.04M beats by $0.02M [8/15/2023 6:10 AM]
12-05-2023	PM	Before the open (May 16)	AIM	Hemispherx BioPharma, Inc.	17.48	-0.08	0.00	-0.08	AIM ImmunoTech GAAP EPS of -$0.08 [5/15/2023 9:28 AM]	0.4240	0.0 (-0.24%)	0.44	0.02 (3.72%)	0.29 - 1.05	96,163	60,000	664
AIM ImmunoTech GAAP EPS of -$0.08 [5/15/2023 9:28 AM]
31-03-2022	AH	5:15 PM ET (Mar 31)	AIM	Hemispherx BioPharma, Inc.	42.87	-0.12	0.00	-0.09	AIM ImmunoTech GAAP EPS of -$0.04 [3/31/2022 4:43 PM]	1.06	0.01 (0.47%)	1.05	-0.01 (-0.94%)	0.55 - 2.51	131,442	240,000	2,101
AIM ImmunoTech GAAP EPS of -$0.04 [3/31/2022 4:43 PM] Investors in Ai-Media Technologies (ASX:AIM) have unfortunately lost 30% over the last year [Mar-29-22 10:17PM] AIMIA REPORTS FOURTH QUARTER 2021 RESULTS [Mar-30-22 07:00AM] AIM ImmunoTech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update [Mar-31-22 04:05PM]
18-05-2021	PM		AIM	Hemispherx BioPharma, Inc.	79.78	-0.08	0.00	-0.22	AIM ImmunoTech EPS in-line, misses on revenue [5/18/2021 7:41 AM]	2.08	0.0 (0.00%)	2.04	-0.04 (-1.92%)	1.60 - 4.30	264,971	800,000	7,771
AIM ImmunoTech EPS in-line, misses on revenue [5/18/2021 7:41 AM] AIM ImmunoTech Provides First Quarter 2021 Business Update [May-18-21 07:30AM]
31-03-2021	PM		AIM	Hemispherx BioPharma, Inc.	84.94	-0.09	0.00	0.00	AIM ImmunoTech EPS misses by $0.02, misses on revenue [3/31/2021 10:39 AM]	0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0